13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-05-19 Event 2025-05-15 SEC 0001415889-25-013680 →

RA CAPITAL MANAGEMENT, L.P. iTeos Therapeutics, Inc.

Stake: 4.90% Shares: 2,134,806 CUSIP: 46565G104 Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
62 filings by this filer
61 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on iTeos Therapeutics, Inc.

FiledFormFilerStakeShares
2025-09-03 SCHEDULE TANG CAPITAL MANAGEMENT LLC 100.00% 10,000 view →
2025-05-14 SCHEDULE RA CAPITAL MANAGEMENT, L.P. 9.90% 4,163,276 view →
2024-11-18 SC Boxer Capital Management, LLC view →
2022-01-06 SC Boxer Capital, LLC view →
2021-12-10 SC MPM BioVentures 2014, L.P. view →
2021-10-19 SC MPM BioVentures 2014, L.P. view →
2021-09-21 SC MPM BioVentures 2014, L.P. view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

FiledFormIssuerStakeShares
2026-01-09 SCHEDULE Cidara Therapeutics, Inc. view →
2025-11-07 SCHEDULE LENZ Therapeutics, Inc. LENZ 13.60% 4,265,106 view →
2025-11-07 SCHEDULE Sionna Therapeutics, Inc. SION 22.60% 10,071,712 view →
2025-11-03 SCHEDULE 89bio, Inc. view →
2025-10-01 SCHEDULE ARS Pharmaceuticals, Inc. SPRY 11.10% 10,940,977 view →
2025-09-30 SCHEDULE PepGen Inc. PEPG 29.20% 20,099,753 view →
2025-08-11 SCHEDULE Cidara Therapeutics, Inc. 13.30% 3,365,523 view →
2025-06-30 SCHEDULE Cidara Therapeutics, Inc. 15.80% 3,365,523 view →
2025-05-14 SCHEDULE iTeos Therapeutics, Inc. 9.90% 4,163,276 view →
2025-05-14 SCHEDULE Werewolf Therapeutics, Inc. HOWL 15.00% 6,746,807 view →
2025-05-09 SCHEDULE LENZ Therapeutics, Inc. LENZ 15.10% 4,260,606 view →
2025-04-30 SCHEDULE Jade Biosciences, Inc. JBIO 4.10% 1,324,954 view →
2025-03-17 SCHEDULE Mineralys Therapeutics, Inc. MLYS 9.90% 6,287,597 view →
2025-03-10 SCHEDULE Janux Therapeutics, Inc. JANX 19.90% 11,971,377 view →
2025-03-03 SCHEDULE 89bio, Inc. 13.70% 20,013,733 view →
2025-02-21 SCHEDULE Solid Biosciences Inc. SLDB 9.90% 7,989,820 view →
2025-02-03 SCHEDULE 89bio, Inc. 15.10% 20,013,733 view →
2024-10-01 SC Wave Life Sciences Ltd. WVE view →
2024-07-01 SC Eliem Therapeutics, Inc. CLYM view →
2024-06-20 SC Aerovate Therapeutics, Inc. JBIO view →
Showing 20 of 61

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →